Articles with "ltv" as a keyword



Real World Experience of Letermovir (LTV) Prophylaxis (Px) for the Prevention of Cytomegalovirus Infection (CMVi) in the Adult CMV Seropositive Recipients (R+) of Allogeneic Hematopoietic Cell Transplantation (HCT) Patients (pts).

Sign Up to like & get
recommendations!
Published in 2019 at "Biology of Blood and Marrow Transplantation"

DOI: 10.1016/j.bbmt.2018.12.590

Abstract: CMVi leads to significant morbidity in R+ HCT and preemptive therapy (PET) has been the standard of care. LTV was FDA-approved in Nov. 2017 for CMVi prevention in R+ HCT. Besides the clinical trials, there… read more here.

Keywords: risk; ltv; hct; cmvi ... See more keywords

Tracking Control Based on Model Predictive Control Using Laguerre Functions With Pole Optimization

Sign Up to like & get
recommendations!
Published in 2022 at "IEEE Transactions on Intelligent Transportation Systems"

DOI: 10.1109/tits.2022.3179613

Abstract: This paper focused on improving a model predictive control (MPC) using Laguerre functions. This study was conducted to achieve high performance while reducing the computational complexity of MPC for autonomous vehicle tracking control. Previous studies… read more here.

Keywords: using laguerre; laguerre functions; control; ltv ... See more keywords

Real World Outcomes of Letermovir Prophylaxis in Unselected High Risk CMV Seropositive Hematopoietic Stem Cell Transplant Recipients

Sign Up to like & get
recommendations!
Published in 2019 at "Blood"

DOI: 10.1182/blood-2019-131365

Abstract: Introduction: Cytomegalovirus (CMV) is a leading cause of morbidity following allogenenic hematopoietic stem cell transplant (HSCT). Letermovir (LTV), an orally available antiviral drug which inhibits the CMV-terminase complex, was recently approved for CMV prophylaxis in… read more here.

Keywords: prophylaxis; risk; ltv; cmv infection ... See more keywords

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Sign Up to like & get
recommendations!
Published in 2024 at "Blood"

DOI: 10.1182/blood-2024-202355

Abstract: Background: The novel CMV DNA terminase inhibitor letermovir (LTV) has been approved effective for prophylaxis of CMV reactivation in HSCT recipients. Concerns have been raised about increased EBV reactivation and delayed immune reconstitution following hematopoietic… read more here.

Keywords: relapse; prophylaxis; ltv group; ltv ... See more keywords

Letermovir primary prophylaxis is associated with reduced and delayed CMV reactivation in haploidentical allohct using ptcy.

Sign Up to like & get
recommendations!
Published in 2025 at "Blood"

DOI: 10.1182/blood-2025-7711

Abstract: Background: The use of letermovir (LTV) in the allogeneic hematopoietic cell transplant has dramatically changed the incidence of cytomegalovirus reactivation (CMVr) with direct effect also on overall survival (OS). Such effect has been retrospectively observed… read more here.

Keywords: disease; cmvr; cmv; ltv ... See more keywords

Evaluation of the effects of asymmetric lumbosacral transitional vertebra on pelvic morphology in dogs using ventrodorsal radiographs

Sign Up to like & get
recommendations!
Published in 2025 at "Acta Veterinaria Scandinavica"

DOI: 10.1186/s13028-024-00785-3

Abstract: A lumbosacral transitional vertebra (LTV) is a congenital anomaly of the caudal vertebral column. It has been associated with asymmetrical canine hip dysplasia (CHD) and cauda equina syndrome (CES) in German Shepherd dogs. This retrospective… read more here.

Keywords: rotation; ltv; ventrodorsal radiographs; transitional vertebra ... See more keywords